Nivolumab,Ipilimumab
BMS
[]
neoadjuvant immunotherapy shows promising results in patients with mmr-deficient colon cancer discusses the exciting results in this touchoncology interview at #esmo22 
Intended for use by Healthcare Professionals (HCPs) only.  It should not be considered medical advice, diagnosis, or treatment recommend

Disclaimer in Linktree